Actively Recruiting
Efficacy of CAD in Screening Colonoscopy to Reduce the Risk of Advanced Adenoma at 3 Years.
Led by University Hospital, Bordeaux · Updated on 2026-03-16
592
Participants Needed
13
Research Sites
259 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The occurrence of interval cancers after colonoscopy raises the possibility of missed lesions. High- performance computer aided diagnosis (CAD) systems have been specially designed for the detection of colorectal lesions (CAD for detection is named CADe). The use of CADe improves adenoma detection in screening colonoscopy. The potential of CADe system in reducing the rate of progression to advanced polyps or interval cancer between two colonoscopies remains still uncertain.
CONDITIONS
Official Title
Efficacy of CAD in Screening Colonoscopy to Reduce the Risk of Advanced Adenoma at 3 Years.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients over 18 years of age with indication for colonoscopy as part of a screening program, after a positive immunological (FIT) test, and/or for personal or family history of colorectal cancer and/or personal history of colonic adenomas
- Written informed consent signed
- Patients covered by a health-care insurance.
You will not qualify if you...
- Failed complete colonoscopy, defined by the absence of cecal intubation and/or the absence of terminal ileum cauterization
- Inadequate bowel preparation (Boston bowel preparation score < 6, and/or least at one part of colon with score 64 1)
- An infiltrative tumor diagnosed during colonoscope insertion not accessible to endoscopic resection and likely to require surgical management
- Patient under guardianship or protection
- Pregnant women
- Not fluent in French or illiterate
- Personal history of inflammatory bowel disease
- Personal history of genetic predisposition of CRC
- Personal history of colonic surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 13 locations
1
CH de la Côte Basque
Bayonne, France, 64100
Not Yet Recruiting
2
CHU Brest la Cavale Blanche
Brest, France, 29200
Not Yet Recruiting
3
Clinique Paris Bercy
Charenton-le-Pont, France, 94220
Not Yet Recruiting
4
CHU de Limoges
Limoges, France, 87042
Not Yet Recruiting
5
Institut Paoli Calmettes
Marseille, France, 13009
Not Yet Recruiting
6
Clinique Jules Verne
Nantes, France, 44300
Not Yet Recruiting
7
CHU Nîmes
Nîmes, France, 30029
Not Yet Recruiting
8
APHP - Hôpital Saint Antoine
Paris, France, 75012
Not Yet Recruiting
9
Aphp-Hegp
Paris, France, 75015
Not Yet Recruiting
10
CHU Bordeaux - Hôpital Haut Lévêque
Pessac, France, 33604
Actively Recruiting
11
CHU de Rennes
Rennes, France, 35000
Not Yet Recruiting
12
Clinique Pasteur
Toulouse, France, 31076
Not Yet Recruiting
13
CHRU de Nancy - Hôpital Brabois Adultes
Vandœuvre-lès-Nancy, France, 54511
Not Yet Recruiting
Research Team
A
Arthur BERGER, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here